Astrosalva Therapeutics Inc., a privately held, preclinical biotechnology company developing treatments for Alexander disease and the cerebral form of adrenoleukodystrophy (cALD), has launched with Unravel Biosciences Inc. as…
Astrosalva Therapeutics Inc., a privately held, preclinical biotechnology company developing treatments for Alexander disease and the cerebral form of adrenoleukodystrophy (cALD), has launched with Unravel Biosciences Inc. as its founding development partner.
Source disclosure
This is a source-linked briefing. Read the original report from Bioworld .